By evaluating expression of circulating miRNAs in sera from patients with oral cancer, we identified 20 miRNAs that are significantly deregulated with oral HRLs.
We furthered these observations by evaluating expression of mir-200c and proteins involved in the induction of EMT following treatment with TGF β1, an EMT inducer, because several signature miRNAs target members of the TGF β response pathway.
Assessed tumor cell characteristics including secretion of matrix metalloproteinase-9 (MMP-9), invasion, and colony formation were fortified by evaluating expression of relevant genes by real-time reverse transcription polymerase chain reaction and by Western blot.
The possible mechanisms of Gent activities were explored by evaluating expression levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 using real-time fluorogenic PCR and expression levels of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) using Western blotting.
As a first application of FiDePa, we studied pathogenic processes in human neoplasms by evaluating expression profiles of 100 glioma patients [WHO grades III and IV, extracted from the Gene Expression Omnibus (GEO; Barrett and Edgar, 2006; Edgar et al., 2002) dataset GDS1815 (Phillips et al., 2006)].
We also determined whether other hormone genes that are primarily expressed in the pituitary gland were altered in pre-symptomatic scrapie-infected mice by evaluating expression levels of Lhb, Tshb, and Fshb in scrapie-and mock-infected mice.
To disclose the molecular basis underlying G1-S phase transition by SSTR1, we evaluated expression of the key regulatory factors that control G1-S checkpoint.
As an alternative means of detecting recombination in the brain, we evaluated expression of eYFP by immunohistochemistry.
This was carried out by evaluating the expression of two kinds of molecules on cells derived from apheretic procedures: (a) Bone Sialoprotein (BSP) and Osteocalcin that are produced by bone cells, histotypically similar to osteosarcoma cells; (b) oncogenes like MET or ErbB2, frequently overexpressed in osteosarcomas.
Since both the PLD isoforms are expressed in BALB/c mice [35], we determined the isoform-specific knockdown of PLD1 by evaluating the expression of PLD2 as well, following the above-mentioned siRNA intravenous administration.
MicroRNA forced expression biological effects were first examined by evaluating the expression of unilineage differentiation surface markers: CD235a that first appears at the basophilic normoblast stage of erythroid differentiation, CD41a as an indicator of megakaryocytic commitment, CD14 distinguishing monocytic differentiation while CD66b reflects granulocytic cell fate.
